// App-Quantinova.ai

e20583 : Risk factors for anthracycline-associated cardiotoxicity.

Researchers

Presenter

  • Raquel E. Reinbolt

Principal Investigators

  • Roshan Patel

  • Charles L. Shapiro

  • Maryam B. Lustberg

  • Xueliang Jeff Pan

  • Cynthia Dawn Timmers

  • Robert Pilarski

Medical Centers

  • Division of Human Genetics and The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • The Breast Program, The Ohio State University Comprehensive Cancer Center and the Stefanie Spielman Comprehensive Breast Center, Columbus, OHThe Ohio State University Comprehensive Cancer Center, Columbus, OHThe Stefanie Spielman Comprehensive Breast Center, Ohio State University Wexner Medical Center, Columbus, OH

  • The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital, Richard J. Solove Research Institute, Columbus, OH

  • The Ohio State University College of Medicine, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Cardiotoxicity

  • Heart muscle disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved